Liao, Mingxiang http://orcid.org/0000-0003-1853-1419
Zhou, Jie http://orcid.org/0000-0002-3626-4732
Wride, Kenton
Lepley, Denise
Cameron, Terri
Sale, Mark http://orcid.org/0000-0002-6239-2359
Xiao, Jim http://orcid.org/0000-0003-3632-2012
Clinical trials referenced in this document:
Documents that mention this clinical trial
FGFR1 amplification in lung squamous cell carcinoma: A systematic review with meta-analysis
https://doi.org/10.1016/j.lungcan.2014.11.009
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer
https://doi.org/10.1007/s13318-022-00773-w
Documents that mention this clinical trial
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer
https://doi.org/10.1007/s13318-022-00773-w
Documents that mention this clinical trial
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer
https://doi.org/10.1007/s13318-022-00773-w
Documents that mention this clinical trial
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer
https://doi.org/10.1007/s13318-022-00773-w
Documents that mention this clinical trial
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer
https://doi.org/10.1007/s13318-022-00773-w
Funding for this research was provided by:
Clovis Oncology
Article History
Accepted: 19 April 2022
First Online: 18 July 2022
Declarations
:
: This analysis was funded by Clovis Oncology, Inc.
: Mingxiang Liao, Kenton Wride, Denise Lepley, Terri Cameron, and Jim Xiao are or were employees of Clovis Oncology, Inc. Mark Sale and Jie Zhou are or were paid consultants for Clovis Oncology, Inc.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All studies were approved by an Institutional Review Board or Independent Ethics Committee.
: Written informed consent was obtained from each patient in all studies included in this manuscript prior to participation.
: Not applicable.
: Requests for de-identified datasets for the results reported in this publication will be made available to qualified researchers following submission of a methodologically sound proposal to medinfo@clovisoncology.com. Data will be made available for such requests following online publication of this article and for 1 year thereafter in compliance with applicable privacy laws, data protection, and requirements for consent and anonymization. Data will be provided by Clovis Oncology.
: Included in supplementary file.
: All authors participated in study conception and research design. ML, JZ, MS, and JX performed data analysis. This article was written by the authors, with medical writing and copy editing support paid for by the sponsor. All authors had full access to the trial data and read and approved the final manuscript.